Cablevision's support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.
Learn More

Send an eCard Today!



Make a tribute gift and send a personalized eCard!

Newly Diagnosed 


Start here to learn about pancreatic cancer and available resources.

Finding Clinical Trials


 A clinical trial is a research study designed to evaluate a new cancer treatment. Patients enrolled in a clinical trial are among the first to receive new treatments before they become widely offered.

Latest News

Tiny Particles in Blood Useful for Early Diagnosis of Pancreatic Cancer


Dr. Raghu Kalluri, a Lustgarten Foundation-funded scientist at MD Anderson Cancer Center, has discovered that a protein called GPC1 is highly expressed on the surface of small, cancer-produced structures called “exosomes”. GPC1-expressing exosomes are released and detectable in the blood, which means they have the potential to become a clinical cancer biomarker.

06.24.15
Read More >

Study Identifies Multiple Genetic Changes Linked to Increased Pancreatic Cancer Risk


One of our own Research Investigators, Alison Klein at Johns Hopkins University School of Medicine, discovered four new genetic variations that may increase the risk for Pancreatic Cancer if it is present in a person's genome, or genetic blueprint.

06.23.15
Read More >

PEGPH20 Comibation Doubles PFS in HA-High Pancreatic Cancer


"Recent clinical work by one of our outstanding ‪grantees‬, Dr. Sunil Hingorani, has shown that, "the addition of the enzyme PEGPH20 to standard nab-paclitaxel and gemcitabine improved progression-free survival (PFS) by 4.9 months compared with the two agents alone in untreated patients with advanced ‪pancreatic‬ ‪cancer‬ with high expression levels of hyaluronan (HA), according to interim findings from a phase II study presented at the 2015 ‪ASCO‬ Annual Meeting."

06.16.15
Read More >

Antibody Fragments Expand What PET Imaging Can 'See' In Mice


“Lustgarten-funded researchers Dr. Hidde Ploegh and Dr. Ralph Weissleder have designed a more sensitive and precise imaging technique to detect and monitor pancreatic tumors.

06.3.15
Read More >

Small Study Shows Genetic Biomarker May Predict Cancer Patients' Response to Immunotherapy Drug


Research findings published in the New England Journal of Medicine and funded in part by The Lustgarten Foundation show promise leveraging certain immunotherapy drugs for a small subset of pancreatic cancer patients where standard therapies have failed.

05.29.15
Read More >

Finding My Treatment For Pancreatic Cancer


The Lustgarten Foundation’s board member, Anne Glauber, explains the innovative treatment she is receiving for her stage IV pancreatic cancer.

05.15.15
Read More >

The Next Shock After a Pancreatic Cancer Diagnosis: Where Are the Treatments?


The Lustgarten Foundation's board member, Ann Glauber, is telling her story about being diagnosed with stage IV pancreatic cancer and her frustration with the lack of treatment options available.

05.11.15
Read More >

A Walk to Remember: Raising Awareness About Pancreatic Cancer


"Pancreatic cancer was something I knew little about until this "silent killer," as it is known, came into our lives with devastating speed and took someone we loved, so much, away, so quickly."

04.30.15
Read More >

Dr. Carl June offers pancreatic cancer patients revolutionary new immunotherapy


With a jointly funded $1.1 million grant provided by the Lustgarten Foundation and the Cancer Research Institute, scientists at the University of Pennsylvania will begin clinical testing of a new form of immunotheraopy, which they anticipate could dramatically improve patient health.

03.31.15
Read More >

2015 Ruth Leff Siegel Award


The pancreas Center is announcing a call for nominations for the third annual, 2015 Ruth Leff Siegel Award.

03.26.15
Read More >

$12 Million translational research grant announced


Cancer Research UK  and The Lustgarten Foundation join with SU2C to fund new Pancreatic Cancer Dream Team.

03.04.15
Read More >

New Clinical Trial


New immunotherapy clinical trial begins with support from SU2C and The Lustgarten Foundation Pancreatic Cancer Dream Team. 

02.10.15
Read More >

Lustgarten foundation Investigators


Multi million dollar grants allow scientists to dedicate more focus to identifying new breakthroughs in pancreatic cancer research and accelerating a path to a cure.  

02.06.15
Read More >

Cablevision's support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303